Benzydamine N-oxide

CAS : 36504-71-9

Ref. 3D-FB18263

Informations sur le produit

• Nom: Benzydamine N-oxide
• Synonymes: N,N-Dimethyl-3-[[1-(phenylmethyl)-1H-indazol-3-yl]oxy]-1-propanamine, 1-Propanamine, N,N-dimethyl-3-((1-(phenylmethyl)-1H-indazol-3-yl)oxy)-, N-oxide
• CAS: 36504-71-9

Description

Benzydamine N-oxide is a polymorphic, michaelis-menten kinetics and pharmacological treatments drug. It has been shown to have anti-inflammatory effects in humans and animals. The main pharmacological targets of benzydamine are the human liver and alveolar type II cells. This drug has low bioavailability but is metabolized by the liver cells into benzydamine n-oxide which can be excreted through urine or bile. The formation rate of benzydamine n-oxide in the human body is about 2% per hour, which is dependent on the enzyme catalysis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 325.4 g/mol
• Formule: C₁₉H₂₃N₃O₂
• Degré de pureté: Min. 90 Area-%
• Couleur/Forme: Powder